Amarin | AMRN - Pre Tax Profit

Stock Price
14.75
Daily Change
0.66 4.68%
Monthly
5.13%
Yearly
36.32%
Q1 Forecast
14.47

Amarin reported $-8.12M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Amarin USD -8.12M 5.34M Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
DBV Technologies USD -33.16M 8.6M Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Halozyme Therapeutics USD 218.96M 14.02M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Neurocrine Biosciences USD 291.8M 132.3M Sep/2025
Novartis USD 4.2B 335M Sep/2025